...
krys-img

Krystal Biotech Inc, Common Stock

KRYS

NSQ

$164.83

+$4

(2.49%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$4.51B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
87.5084
Volume info-icon
This is the total number of shares traded during the most recent trading day.
708.75K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.82
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$107.5 L
$219.34 H
$164.83

About Krystal Biotech Inc, Common Stock

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). The company also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameKRYSSectorS&P500
1-Week Return0.73%-2.12%-3%
1-Month Return-7.45%-3.42%-0.73%
3-Month Return-10.5%-11.13%2.87%
6-Month Return-3.73%-5.74%7.17%
1-Year Return45.94%3.97%25.31%
3-Year Return135.47%1.05%28.38%
5-Year Return187.81%34.37%81.89%
10-Year Return1449.15%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue----50.70M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue974.00K1.85M2.77M4.05M3.09M[{"date":"2019-12-31","value":24.02,"profit":true},{"date":"2020-12-31","value":45.65,"profit":true},{"date":"2021-12-31","value":68.29,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":76.3,"profit":true}]
Gross Profit(974.00K)(1.85M)(2.77M)(4.05M)47.60M[{"date":"2019-12-31","value":-2.05,"profit":false},{"date":"2020-12-31","value":-3.89,"profit":false},{"date":"2021-12-31","value":-5.82,"profit":false},{"date":"2022-12-31","value":-8.52,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)93.90%[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses22.08M33.00M68.28M120.20M157.33M[{"date":"2019-12-31","value":14.03,"profit":true},{"date":"2020-12-31","value":20.97,"profit":true},{"date":"2021-12-31","value":43.4,"profit":true},{"date":"2022-12-31","value":76.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(22.08M)(33.00M)(68.28M)(145.20M)(109.73M)[{"date":"2019-12-31","value":-2208100000,"profit":false},{"date":"2020-12-31","value":-3299900000,"profit":false},{"date":"2021-12-31","value":-6827500000,"profit":false},{"date":"2022-12-31","value":-14519600000,"profit":false},{"date":"2023-12-31","value":-10972700000,"profit":false}]
Total Non-Operating Income/Expense5.99M1.66M(2.59M)10.44M145.25M[{"date":"2019-12-31","value":4.12,"profit":true},{"date":"2020-12-31","value":1.15,"profit":true},{"date":"2021-12-31","value":-1.78,"profit":false},{"date":"2022-12-31","value":7.19,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(19.09M)(32.17M)(69.57M)(139.97M)12.90M[{"date":"2019-12-31","value":-148,"profit":false},{"date":"2020-12-31","value":-249.41,"profit":false},{"date":"2021-12-31","value":-539.43,"profit":false},{"date":"2022-12-31","value":-1085.33,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes(2.99M)1.64M2.73M34.05M1.97M[{"date":"2019-12-31","value":-8.79,"profit":false},{"date":"2020-12-31","value":4.83,"profit":true},{"date":"2021-12-31","value":8.02,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":5.77,"profit":true}]
Income After Taxes(16.09M)(33.81M)(72.30M)(174.02M)10.93M[{"date":"2019-12-31","value":-147.23,"profit":false},{"date":"2020-12-31","value":-309.29,"profit":false},{"date":"2021-12-31","value":-661.36,"profit":false},{"date":"2022-12-31","value":-1591.86,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Continuous Operations(19.09M)(33.00M)(69.57M)(139.97M)10.93M[{"date":"2019-12-31","value":-174.61,"profit":false},{"date":"2020-12-31","value":-301.86,"profit":false},{"date":"2021-12-31","value":-636.39,"profit":false},{"date":"2022-12-31","value":-1280.42,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(19.09M)(32.17M)(69.57M)(139.97M)10.93M[{"date":"2019-12-31","value":-174.61,"profit":false},{"date":"2020-12-31","value":-294.25,"profit":false},{"date":"2021-12-31","value":-636.39,"profit":false},{"date":"2022-12-31","value":-1280.42,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
EPS (Diluted)(1.22)(1.70)(3.06)(4.51)(3.40)[{"date":"2019-12-31","value":-122,"profit":false},{"date":"2020-12-31","value":-170,"profit":false},{"date":"2021-12-31","value":-306,"profit":false},{"date":"2022-12-31","value":-451,"profit":false},{"date":"2023-12-31","value":-340,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

KRYS
Cash Ratio 6.57
Current Ratio 7.97
Quick Ratio 7.76

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

KRYS
ROA (LTM) 4.58%
ROE (LTM) 6.38%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

KRYS
Debt Ratio Lower is generally better. Negative is bad. 0.10
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.90

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

KRYS
Trailing PE 89.85
Forward PE 28.90
P/S (TTM) 19.15
P/B 5.22
Price/FCF 80
EV/R 16.75
EV/Ebitda 22.34

FAQs

What is Krystal Biotech Inc share price today?

Krystal Biotech Inc (KRYS) share price today is $164.83

Can Indians buy Krystal Biotech Inc shares?

Yes, Indians can buy shares of Krystal Biotech Inc (KRYS) on Vested. To buy Krystal Biotech Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KRYS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Krystal Biotech Inc be purchased?

Yes, you can purchase fractional shares of Krystal Biotech Inc (KRYS) via the Vested app. You can start investing in Krystal Biotech Inc (KRYS) with a minimum investment of $1.

How to invest in Krystal Biotech Inc shares from India?

You can invest in shares of Krystal Biotech Inc (KRYS) via Vested in three simple steps:

  • Click on Sign Up or Invest in KRYS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Krystal Biotech Inc shares
What is Krystal Biotech Inc 52-week high and low stock price?

The 52-week high price of Krystal Biotech Inc (KRYS) is $219.34. The 52-week low price of Krystal Biotech Inc (KRYS) is $107.5.

What is Krystal Biotech Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Krystal Biotech Inc (KRYS) is 87.5084

What is Krystal Biotech Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Krystal Biotech Inc (KRYS) is 5.22

What is Krystal Biotech Inc dividend yield?

The dividend yield of Krystal Biotech Inc (KRYS) is 0.00%

What is the Market Cap of Krystal Biotech Inc?

The market capitalization of Krystal Biotech Inc (KRYS) is $4.51B

What is Krystal Biotech Inc’s stock symbol?

The stock symbol (or ticker) of Krystal Biotech Inc is KRYS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top